January 10, 2014
Jena (Germany) -- After a two year period of development Analytik Jena has launched an innovative technology to enrich and isolate free-circulating DNA. Free-circulating DNA occurs in plasma, serum, and urine, among other things, but only in small fragments and very low concentrations. In order to isolate them, large sample volumes and large quantities of [...]
January 10, 2014
CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that the company’s TRU FLU® assay received FDA clearance for an analytical sensitivity claim for the novel avian Influenza H7N9 strain, A/Anhui/1/2013. TRU FLU® is a rapid immunoassay that detects influenza A and influenza B viruses in 15 minutes in human respiratory specimens. New strains of [...]
Micromeritics New 3Flex – Innovative, Versatile High-Resolution Surface Characterization Analyzer
January 10, 2014
Micromeritics 3Flex Surface Characterization Analyzer is a fully automated, three-station instrument capable of high-performance physisorption, mesopore, micropore, and chemisorption analyses with superior accuracy, resolution, and data reduction. Each analysis station is upgradeable from mesopore to micropore with the option of designating one station for chemisorption analyses. All analysis stations can be configured for krypton analysis [...]
January 10, 2014
AARHUS, Denmark, & QUESTEMBERT, France -- CLC bio, a QIAGEN company (QGEN)(QIA.F), today announced in collaboration with Korilog the release of the KLAST plug-in for CLC Genomics Workbench and CLC Main Workbench to accelerate the analysis of data from next-generation sequencing (NGS). KLAST is a new sequence similarity search tool which builds on a highly [...]
New financing and extension of Biognosys’ management team
January 10, 2014
End of December 2013 Biognosys has secured USD 1 million financing in form of a convertible loan. This financing will ensure future growth of the company by expanding its commercial operations and product development. In addition, Biognosys strengthened the existing management team by appointing Russell Golson as Director of Sales and Dr. Lukas Reiter as [...]
Cerilliant Introduces New Snap-N-Spike® Internal Standards of Nicotine Metabolites
January 9, 2014
ROUND ROCK, TEXAS – Cerilliant introduces two new Certified Spiking Solutions® of nicotine metabolites anabasine-D4 HCl and trans-3’-Hydroxycotinine-D3 at concentrations of 100 µg/mL in methanol. These solution standards can be used as internal standards spiked into patient samples or in isotope dilution methods for quantification of anabasine and 3-hydroxycotinine levels in nicotine screening and other [...]
Release of Chip-Mate, a Chip-based nano-LC Ion Source for Mass Spectrometers
January 9, 2014
Ithaca, NY – Advion, Inc., a leading instruments and consumables developer for the life sciences industry, announced today the release of the latest in chip-based technology, the Chip-Mate™. The Chip-Mate is an ESI Chip®-based nano-LC ion source for applications requiring small micron ID HPLC columns and nanoelectrospray ionization (nano-ESI). This latest product offering from Advion [...]
Dako to Collaborate with Merck on Development of Companion Diagnostics for Cancer Treatment
January 9, 2014
GLOSTRUP, Denmark -- Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Merck to develop companion diagnostic tests for oncology drugs currently in Merck's development pipeline. "Dako is relentless in its commitment to fighting cancer, together with our customers and pharma partners," said Jacob Thaysen, vice president and [...]
TTP Labtech acquires assets in fluorescence lifetime technology
January 9, 2014
Royston, UK – Significant improvements in assay reagents and availability of High Throughput Screen (HTS)-compatible readers has propelled fluorescence lifetime (FLT) technology to the vanguard of cost-effective screening technologies. TTP Labtech has consolidated its position in the field with today’s announcement of the purchase of assets from AssayMetrics Limited, Cardiff, UK a leading company in [...]
January 9, 2014
SAN DIEGO -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading benefits provider, to provide coverage for the MaterniT21™ PLUS laboratory-developed test (LDT). The addition of this contract brings the number of [...]
